MAURA SMITH: Open Payments
NPI 1255751996 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 30 payments from 12 companies in 2025. Trend: 2023 $311 · 2024 $401 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $69 |
| Aimmune Therapeutics, Inc. | 2 | $57 |
| Ardelyx, Inc. | 2 | $45 |
| Celltrion USA Inc. | 2 | $36 |
| Enterra Medical, Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $30 |
| Dynavax Technologies Corporation | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $25 |
Products named: SKYRIZI, RINVOQ, ENTYVIO, ZENPEP, IBSRELA, VEGZELMA, DUPIXENT, OMVOH.
Industry payments across TX — which companies pay providers there.
